{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:45Z","timestamp":1792785945486,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Prinses Beatrix Fonds","award":["WAR08-12"],"award-info":[{"award-number":["WAR08-12"]}],"id":[{"id":"https:\/\/ror.org\/0011f2t53","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Netherlands Organization for Scientific Research","award":["916.10.148"],"award-info":[{"award-number":["916.10.148"]}],"id":[{"id":"https:\/\/ror.org\/04jsz6e67","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Brain Foundation of the Netherlands","award":["FS2008(1)-28"],"award-info":[{"award-number":["FS2008(1)-28"]}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["15853"],"award-info":[{"award-number":["15853"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"Greek General Secretariat of Research and Technology","doi-asserted-by":"crossref","award":["1154"],"award-info":[{"award-number":["1154"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorder and Stroke","doi-asserted-by":"crossref","award":["R24EY014837"],"award-info":[{"award-number":["R24EY014837"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004923","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["186874"],"award-info":[{"award-number":["186874"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003157","name":"Myasthenia Gravis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.expneurol.2015.02.025","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T08:24:09Z","timestamp":1425371049000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model\u2014Recommendations for methods and experimental designs"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5530-2140","authenticated-orcid":false,"given":"Linda L.","family":"Kusner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<616::AID-IMMU616>3.0.CO;2-I","article-title":"Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor","volume":"28","author":"Barchan","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.expneurol.2015.02.025_bb0015","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.142.8.2654","article-title":"Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6","volume":"142","author":"Biesecker","year":"1989","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2015.02.025_bb0020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/mus.880171208","article-title":"Passive transfer of seronegative myasthenia gravis to mice","volume":"17","author":"Burges","year":"1994","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb9880","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0165-5728(87)90067-1","article-title":"Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein","volume":"13","author":"Buschman","year":"1987","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2249.2006.03198.x","article-title":"Complement membrane attack is required for endplate damage and clinical disease in passive experimental myasthenia gravis in Lewis rats","volume":"146","author":"Chamberlain-Banoub","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.expneurol.2015.02.025_bb0030","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.expneurol.2015.02.025_bb0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0265021505000992","article-title":"Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model","volume":"22","author":"De Haes","year":"2005","journal-title":"Eur. J. Anaesthesiol."},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1998.4535","article-title":"The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis","volume":"87","author":"Dedhia","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"5","key":"10.1016\/j.expneurol.2015.02.025_bb0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00005072-197609000-00008","article-title":"Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations","volume":"35","author":"Engel","year":"1976","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.29.2.179","article-title":"Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor","volume":"29","author":"Engel","year":"1979","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/intimm\/9.9.1311","article-title":"Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library","volume":"9","author":"Farrar","year":"1997","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/eji.200425671","article-title":"Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies","volume":"35","author":"Fostieri","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2004.05.002","article-title":"Short-circuiting autoimmune disease by target-tissue-derived nitric oxide","volume":"113","author":"Garcia","year":"2004","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(02)00023-2","article-title":"Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis","volume":"106","author":"Garcia","year":"2003","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2015.02.025_bb0075","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0090","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.4049\/jimmunol.150.9.4093","article-title":"Age-related resistance to experimental autoimmune myasthenia gravis in rats","volume":"150","author":"Graus","year":"1993","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2015.02.025_bb0080","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.4049\/jimmunol.154.12.6382","article-title":"Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis","volume":"154","author":"Graus","year":"1995","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2015.02.025_bb0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies","volume":"158","author":"Graus","year":"1997","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.expneurol.2015.02.025_bb0095","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1074\/jbc.M609858200","article-title":"In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubata","volume":"282","author":"Hepburn","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2015.02.025_bb0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-5728(97)00016-7","article-title":"Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG","volume":"75","author":"Hoedemaekers","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.02.025_bb0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1749-6632.1998.tb10981.x","article-title":"Differential susceptibility of young and old rat neuromuscular junctions to antibody-mediated AChR degradation in experimental autoimmune myasthenia gravis","volume":"841","author":"Hoedemaekers","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.expneurol.2015.02.025_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(03)00745-2","article-title":"Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer","volume":"548","author":"Hwang","year":"2003","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","article-title":"Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis","volume":"189","author":"Kaminski","year":"2004","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.expneurol.2006.06.003","article-title":"Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia","volume":"202","author":"Kaminski","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.02.025_bb0125","series-title":"Electrodiagnosis in Disease of Nerve and Muscle: Principles and Practice","author":"Kimura","year":"2001"},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0130","doi-asserted-by":"crossref","first-page":"e108327","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"Kordas","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clim.2006.07.005","article-title":"Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis","volume":"121","author":"Krolick","year":"2006","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/cimm.1996.0209","article-title":"Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis","volume":"172","author":"Krolick","year":"1996","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mus.23448","article-title":"Cell surface complement regulators moderate experimental myasthenia gravis pathology","volume":"47","author":"Kusner","year":"2013","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.expneurol.2015.02.025_bb0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"Kusner","year":"2014","journal-title":"Muscle Nerve"},{"issue":"5\u20136","key":"10.1016\/j.expneurol.2015.02.025_bb0155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/08916930903518099","article-title":"Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis","volume":"43","author":"Lagoumintzis","year":"2010","journal-title":"Autoimmunity"},{"issue":"5762","key":"10.1016\/j.expneurol.2015.02.025_bb0160","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/285238a0","article-title":"Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors","volume":"285","author":"Lennon","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.02.025_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1981.tb33725.x","article-title":"Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity","volume":"377","author":"Lennon","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2015.02.025_bb0170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0175","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI0216086","article-title":"Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection","volume":"110","author":"Lin","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb0185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"issue":"Pt C","key":"10.1016\/j.expneurol.2015.02.025_bb0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0076-6879(81)74031-X","article-title":"Production and assay of antibodies to acetylcholine receptors","volume":"74","author":"Lindstrom","year":"1981","journal-title":"Methods Enzymol."},{"issue":"8","key":"10.1016\/j.expneurol.2015.02.025_bb0190","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.178.8.5390","article-title":"Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade","volume":"178","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0195","first-page":"7","article-title":"Effect of passive transfer of myasthenic serum on mechanical, electrical and neuromuscular transmission properties of mouse skeletal muscle","volume":"49","author":"Losavio","year":"1989","journal-title":"Medicina (B Aires)"},{"issue":"Pt 10","key":"10.1016\/j.expneurol.2015.02.025_bb0200","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/awh612","article-title":"Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis","volume":"128","author":"Losen","year":"2005","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0205","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/eji.1830220939","article-title":"Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.expneurol.2015.02.025_bb0210","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","article-title":"Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen","volume":"82","author":"Matthews","year":"2002","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2006.03205.x","article-title":"The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice","volume":"146","author":"Morgan","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-510X(88)90170-0","article-title":"Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect","volume":"84","author":"Mossman","year":"1988","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-1759(90)90079-B","article-title":"A neonatally tolerant mouse model to assess pathogenicity of human autoantibodies","volume":"127","author":"Mundlos","year":"1990","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(99)00259-3","article-title":"Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor","volume":"104","author":"Papanastasiou","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2249.2000.01202.x","article-title":"Treatment of passively transferred experimental autoimmune myasthenia gravis using papain","volume":"120","author":"Poulas","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb0240","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4049\/jimmunol.169.3.1579","article-title":"Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis","volume":"169","author":"Reyes-Reyna","year":"2002","journal-title":"J. Immunol."},{"issue":"5774","key":"10.1016\/j.expneurol.2015.02.025_bb0245","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/286738a0","article-title":"Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia","volume":"286","author":"Richman","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.02.025_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","article-title":"How myasthenia gravis alters the safety factor for neuromuscular transmission","volume":"201\u2013202","author":"Ruff","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21536","article-title":"Novel complement inhibitor limits severity of experimentally myasthenia gravis","volume":"65","author":"Soltys","year":"2009","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2015.02.025_bb0260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mus.880090404","article-title":"Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab\u2032)2 hybrid molecules","volume":"9","author":"Sterz","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.02.025_bb0005","series-title":"Chronic diseases. The Laboratory Primate. S. Wolfe-Coote","first-page":"417","author":"'t Hart","year":"2005"},{"issue":"5513","key":"10.1016\/j.expneurol.2015.02.025_bb0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/256128a0","article-title":"Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor","volume":"256","author":"Tarrab-Hazdai","year":"1975","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0270","first-page":"13","article-title":"Induction of experimental myasthenia gravis in rhesus monkeys: a model for the study of the human disease","volume":"5","author":"Toro-Goyco","year":"1986","journal-title":"P. R. Health Sci. J."},{"issue":"4212","key":"10.1016\/j.expneurol.2015.02.025_bb0275","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.expneurol.2015.02.025_bb0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Toyka","year":"1977","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2015.02.025_bb0285","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jnnp.43.9.836","article-title":"Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG","volume":"43","author":"Toyka","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0300","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.expneurol.2015.02.025_bb0305","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/S0021-9258(19)68891-5","article-title":"Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies","volume":"256","author":"Tzartos","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2015.02.025_bb0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0014-5793(83)80688-7","article-title":"Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor","volume":"158","author":"Tzartos","year":"1983","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.expneurol.2015.02.025_bb0310","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4049\/jimmunol.134.4.2343","article-title":"Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera","volume":"134","author":"Tzartos","year":"1985","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2015.02.025_bb0290","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J. Neuroimmunol."},{"issue":"5844","key":"10.1016\/j.expneurol.2015.02.025_bb0315","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.expneurol.2015.02.025_bb0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.880130604","article-title":"Single-fiber electromyography in experimental autoimmune myasthenia gravis","volume":"13","author":"Verschuuren","year":"1990","journal-title":"Muscle Nerve"},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2015.02.025_bb0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-5728(92)90043-K","article-title":"Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis","volume":"36","author":"Verschuuren","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.02.025_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","article-title":"Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor","volume":"52","author":"Vrolix","year":"2014","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.expneurol.2015.02.025_bb0335","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1212\/WNL.36.5.612","article-title":"Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment","volume":"36","author":"Whiting","year":"1986","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.expneurol.2015.02.025_bb0340","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp.46.5.377","article-title":"Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation","volume":"46","author":"Wilson","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.expneurol.2015.02.025_bb0345","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jnnp.46.5.383","article-title":"Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis","volume":"46","author":"Wilson","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"13","key":"10.1016\/j.expneurol.2015.02.025_bb0350","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","article-title":"Chronic thyroiditis and autoimmunization","volume":"164","author":"Witebsky","year":"1957","journal-title":"J. Am. Med. Assoc."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2015.02.025_bb0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"Wood","year":"1997","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.expneurol.2015.02.025_bb0360","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.expneurol.2015.02.025_bb0365","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","article-title":"Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis","volume":"179","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.02.025_bb0370","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1167\/iovs.14-14422","article-title":"RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment","author":"Zhou","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T11:41:30Z","timestamp":1717760490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":75,"alternative-id":["S0014488615000552"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.025","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model\u2014Recommendations for methods and experimental designs","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}